In the field of treatment, the Pompidou Group
is focusing on signalling problems in day-to-day practice, which are not addressed or
acknowledged by current policies or research.
It strives to promote standards for good practice
and to identify priorities and needs.
• To improve the treatment and care of specific groups, by adapting treatment to new trends,
substances and patterns of consumption
• To assess the results of different modalities of treatment
• To evaluate risk reduction interventions and measures to reduce harm to society
Regulations governing the use of agonist
medication in the Opioid Dependence
In most countries, the prescription of
agonists in the treatment of opioid-dependent persons is
subject to restrictions which significantly impede access to
care. At the “Third Francophone Colloquy on the Treatment of
Opioid Dependence” held in Geneva on 18 and 19 October 2012,
the Swiss Federal Department of Public Health commissioned a
comparative study of the relevant regulations in five
countries: Switzerland, France, Canada, Belgium and Tunisia.|
to participate in the draft of the
on framework and support measures for
opioid dependence treatment including the prescription of
A working paper has been
made publicly available for the purpose
of collecting comments and suggestions.
will find more information
Treatment Systems Overview
The Pompidou Group is focusing its work in drug treatment field on providing an overview of how treatment systems function in different countries, how treatment guidelines are developed and implemented, how to respond to new trends in drugs consumption, notably to the use of stimulant drugs. Another focus is drugs and prisons where standards concerning prisons developed within the framework of the Council of Europe serve as a basis for the Pompidou Group’s comprehensive approach to treatment and rehabilitation of drug using offenders.
Two overviews presenting the treatment systems of 28 countries were published:
Treatment systems overview (October 2010) and
Treatment systems overview in South-East Europe (March 2011). They provide a description of the epidemiology, the history of drug treatment and the organisation of treatment services across Europe.
The use of stimulant drugs is increasing and the types of stimulants circulating among the European population seem to be more differentiated than before. This results in problems for prevention, treatment and harm reduction.
Facing this issue, the Pompidou Group organised a
conference in May 2010 to summarise important developments in treatment of stimulant drugs use.
Link to the conference file
Principles of knowledge-based medicine are useful for
drug treatment as it is in any other parts of medicine. A conference on bridging the gap between clinical practice and evidence-based practice in
the development of guidelines and recommendations for drug treatment took place in May 2009.
Link to the conference file
The Pompidou Group acknowledges that examples of the effective treatment include offers of treatment services that
combine all available sources of support, at various levels, including from peer groups, from
family and from others. The common denominators of examples of good practice include: a high
level of flexibility and the possibility for effective, intersectoral cooperation between law-enforcement,
social and health services.